Skip to main navigation
Skip to search
Skip to main content
Prinses Máxima Centrum Home
Nederlands
English
Search content at Prinses Máxima Centrum
Home
Profiles
Research Groups
Equipment
Research output
Prizes
Activities
Press/Media
Proteasome inhibition as novel treatment strategy in leukaemia
J. Vink
, J. Cloos
,
G. J.L. Kaspers
Research output
:
Contribution to journal
›
Review article
›
peer-review
37
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Proteasome inhibition as novel treatment strategy in leukaemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Leukemia
100%
Novel Treatments
100%
Proteasome Inhibition
100%
Multiple Myeloma
33%
Leukaemic Cells
33%
Cancer Cells
16%
Apoptosis
16%
Deregulation
16%
Normal Hematopoietic Stem Cells
16%
Leukemic Stem Cells
16%
Cellular Proteins
16%
Clinical Application
16%
Bortezomib
16%
Drug Exposure
16%
Multiple Pathways
16%
Clinical Aspects
16%
Protease Inhibitors
16%
Therapeutic Index
16%
Biological Aspects
16%
Medicine and Dentistry
Leukemia
100%
Proteasome
100%
Multiple Myeloma
33%
Malignant Neoplasm
16%
Cancer Cell
16%
Cell Line
16%
Clinical Feature
16%
Stem Cell
16%
Programmed Cell Death
16%
Therapeutic Window
16%
Bortezomib
16%
Drug Exposure
16%
Antileukemic Agent
16%
Proteasome Inhibitor
16%
Cell Protein
16%
Hematopoietic Cell
16%
Pharmacology, Toxicology and Pharmaceutical Science
Leukemia
100%
Proteasome
100%
Malignant Neoplasm
33%
Multiple Myeloma
33%
Therapeutic Window
16%
Bortezomib
16%
Clinical Feature
16%
Antileukemic Agent
16%
Cell Protein
16%
Proteasome Inhibitor
16%
Veterinary Science and Veterinary Medicine
Stem Cell
100%
Cancer Cell
100%
Hematopoietic Cell
100%
Immunology and Microbiology
Proteasome
100%
Multiple Myeloma
28%
Stem Cell
14%
Hematopoietic Cell
14%
Cancer Cell
14%
Cell Line
14%
Drug Exposure
14%